Bioelectronic Medicine Startup Raises $180M Series C
Corvus Neurotech closes a $180 million Series C to fund a pivotal trial of a splenic nerve implant for Crohn’s disease, the largest bet yet on bioelectronic medicine as an alternative to biologics.